BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$672M |
| 2 |
Microsoft
MSFT
|
+$541M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$441M |
| 4 |
Pfizer
PFE
|
+$425M |
| 5 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$420M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$805M |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$535M |
| 3 |
Lam Research
LRCX
|
+$482M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$359M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$328M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.25% |
| 2 | Financials | 7.39% |
| 3 | Consumer Discretionary | 7.31% |
| 4 | Healthcare | 6.72% |
| 5 | Communication Services | 5.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VNET
3551
VNET Group
VNET
$2.1B
| $29.9K | ﹤0.01% |
7,323
+97
| +1% | +$233 |
|
|
STRS
3552
DELISTED
STRATUS PPTYS INC
STRS
| $29.6K | ﹤0.01% |
1,140
+126
| +12% | +$3.27K |
|
3553
Arq
ARQ
$102M
| $29.1K | ﹤0.01% |
4,959
+365
| +8% | +$2.22K |
|
|
ADVM
3554
DELISTED
Adverum Biotechnologies
ADVM
| $29.1K | ﹤0.01% |
4,146
+2,649
| +177% | +$19.2K |
|
3555
AMREP Corp
AXR
$119M
| $28.9K | ﹤0.01% |
+973
| New | +$22.5K |
|
3556
OptimizeRx
OPRX
$155M
| $28.5K | ﹤0.01% |
3,690
+2,414
| +189% | +$21.5K |
|
3557
PetMed Express
PETS
$42.1M
| $28.4K | ﹤0.01% |
7,705
-8,812
| -53% | -$31.2K |
|
3558
Imperial Oil
IMO
$63.4B
| $28.2K | ﹤0.01% |
+400
| New | +$28.3K |
|
3559
Metagenomi Therapeutics
MGX
$47.2M
| $27.8K | ﹤0.01% |
12,799
+7,256
| +131% | +$25.2K |
|
3560
Biglari Holdings Class B
BH
$1.22B
| $27.5K | ﹤0.01% |
160
+36
| +29% | +$6.55K |
|
3561
Invesco FTSE RAFI Emerging Markets ETF
PXH
$1.96B
| $27.4K | ﹤0.01% |
+1,250
| New | +$25.6K |
|
|
ALMS
3562
Alumis Inc
ALMS
$3.23B
| $27.4K | ﹤0.01% |
+2,567
| New | +$31.1K |
|
3563
Critical Metals Corp
CRML
$969M
| $27.3K | ﹤0.01% |
3,674
+1,074
| +41% | +$9.64K |
|
3564
InfuSystem Holdings
INFU
$246M
| $27.3K | ﹤0.01% |
4,076
+1,626
| +66% | +$10.5K |
|
3565
X4 Pharmaceuticals
XFOR
$435M
| $27.2K | ﹤0.01% |
1,357
+787
| +138% | +$16.4K |
|
3566
NACCO Industries
NC
$311M
| $27.2K | ﹤0.01% |
959
-325
| -25% | -$9.18K |
|
3567
NI Holdings
NODK
$318M
| $27.1K | ﹤0.01% |
1,731
+122
| +8% | +$1.85K |
|
3568
BioXcel Therapeutics
BTAI
$35.8M
| $27.1K | ﹤0.01% |
2,774
-14,297
| -84% | -$192K |
|
3569
Occidental Petroleum Corp Warrants
OXY.WS
$33.6B
| $27K | ﹤0.01% |
908
| – | – |
|
3570
Invesco FTSE RAFI US 1000 ETF
PRF
$10.1B
| $26.7K | ﹤0.01% |
+657
| New | +$25.8K |
|
3571
Cartesian Therapeutics
RNAC
$267M
| $26.6K | ﹤0.01% |
1,651
+909
| +123% | +$14.2K |
|
3572
Mammoth Energy Services
TUSK
$156M
| $26.6K | ﹤0.01% |
6,504
+1,567
| +32% | +$5.74K |
|
3573
Gilat Satellite Networks
GILT
$890M
| $26.6K | ﹤0.01% |
+5,038
| New | +$23.2K |
|
3574
New Mountain Finance
NMFC
$735M
| $26.4K | ﹤0.01% |
+2,200
| New | +$26.9K |
|
|
SCPH
3575
DELISTED
scPharmaceuticals
SCPH
| $26.2K | ﹤0.01% |
5,753
+3,101
| +117% | +$15K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2024 Portfolio in Review
As of Q3 2024, BNP Paribas Financial Markets held 4,296 positions worth $149B, up 21% from $123B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
BNP Paribas Financial Markets's Q3 2024 filing shows 266 new, 2,153 increased, 1,264 reduced and 157 closed positions. Its largest new stake was Ferguson: 319,382 shares worth $63.4M. The largest sale was Visa, an estimated $805M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q3 2024 buy was Ferguson: 319,382 shares worth $63.4M.
- BNP Paribas Financial Markets added most to NVIDIA in Q3 2024, an estimated $672M increase.
- BNP Paribas Financial Markets's biggest Q3 2024 reduction was Visa, cutting an estimated $805M.
- BNP Paribas Financial Markets fully exited Lam Research in Q3 2024, selling an estimated $482M.
- BNP Paribas Financial Markets's ten largest holdings make up 20% of its $149B portfolio in Q3 2024.
- BNP Paribas Financial Markets opened 266 new positions and closed 157 in Q3 2024.
- BNP Paribas Financial Markets's portfolio value rose 21% quarter-over-quarter to $149B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2024, filed 13 Nov 2024.